To Understand the Combined Effect of Therapeutic Vomiting and Internal Administration of Saraswata Choorna in Reducing Excessive Daytime Sleepiness
Phase 3
Completed
- Conditions
- Health Condition 1: G471- Hypersomnia
- Registration Number
- CTRI/2020/01/022704
- Lead Sponsor
- Dr ARATHY MENO
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 10
Inclusion Criteria
Patients with a score ranging from 10-24 in the Modified Epworth Sleepiness Scale.
Persons who are not having sleep debt ââ?¬â?? assessed by the Pittsburgh Sleep Quality Scale and having a score of less than 5.
Persons who are eligible for Vamana.
Exclusion Criteria
Patients who are diagnosed with systemic, metabolic disorders and psychiatric disorders.
Pregnant women, lactating mothers and children.
Body Mass Index (BMI) of less than 18 kg/m2 and greater than 25 kg/m2.
Usage of illicit drugs.
Those who are taking over the counter medications.
Smokers, alcoholic persons, patients taking antidepressants or hormone replacement therapy or have a current diagnosis of Post-traumatic stress disorder.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method MODIFIED EPWORTH SLEEPINESS SCALE SCORETimepoint: 1)Before intervention 0th day <br/ ><br>2)After intervention approximately on 52nd day
- Secondary Outcome Measures
Name Time Method ot ApplicableTimepoint: Not Applicable